Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × pertuzumab × Clear all

Status

Recruiting 7 Completed 4 Unknown 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 HER2-positive Breast Cancer 2 Neoplasms 1 Locally Advanced Breast Cancer 1 HER2+ Early or Locally Advanced Breast Cancer 1 HER2+ Breast Cancer 1 Gastrointestinal Neoplasms 1 Feasibility 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasm Female 1 Brain Neoplasms 1

Interventions

Drug Therapy 16 Exercise 15 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 9 Radiotherapy 9 pembrolizumab 8 Paclitaxel 8 Dexamethasone 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 6 Interviews as Topic 6 Fluorouracil 6 Cisplatin 6 Biopsy 6 apatinib 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Gemcitabine 5 Cyclophosphamide 5 atezolizumab 4 Therapeutics 4 Rivaroxaban 4 Radiosurgery 4 Positron Emission Tomography Computed Tomography 4 Nutritional Status 4 Methylprednisolone 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05912062 2023-09-29

BiOnHER

Institut Català d'Oncologia

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡